Jon T. Holmlund
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Jon T. Holmlund
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA.
6
| Private Company | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jon T. Holmlund via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal General Counsel | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Chairman Founder Corporate Officer/Principal | |
| NEA 12 GP LLC | Corporate Officer/Principal | ||
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chairman Chairman | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
| Drexel University | College/University | Undergraduate Degree Masters Business Admin | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| San Diego State University | College/University | Graduate Degree Masters Business Admin | |
| New York University | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of San Diego | College/University | Masters Business Admin Undergraduate Degree | |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Lpath Therapeutics, Inc.
 Lpath Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., Lpath Therapeutics, Inc. develops pharmaceutical products focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. The private company is based in San Diego, CA. Lpath Therapeutics was acquired by Neighborhood Connections, Inc. on November 30, 2005 for $23.13 million. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Founder | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Smithkline Clinical Laboratories | President | ||
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor Private Equity Investor | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree Doctorate Degree | |
Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
 Jiangsu Yasheng Pharmaceutical Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Yasheng Pharmaceutical Development Co. Ltd. develops and produces pharmaceutical products. It focuses on research and development of structure-based molecule for cancer drugs. The company was founded by Dajun Yang, Ming Guo, and Shaomeng Wang in 2009 and is headquartered in Hong Kong. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Lomai Corp. | Director/Board Member | ||
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Biotechnology | Director/Board Member | |
Oncopia Therapeutics, Inc.
 Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| HISTOGEN INC. | Biotechnology | Chairman Chief Executive Officer | |
| CONTEXT THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Verenigd Koninkrijk | 2 |
| China | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 224 |
| Corporate Officer/Principal | 144 |
| Independent Dir/Board Member | 58 |
| Chairman | 45 |
| Director of Finance/CFO | 42 |
Sterkste connecties
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Michael Powell | 48 |
| Frank Torti | 35 |
| Dan Kisner | 29 |
| Henry Skinner | 29 |
| Emmett Cunningham | 28 |
| Thomas Dyrberg | 24 |
| Campbell Murray | 23 |
| Jeffrey Black | 20 |
| John Reed | 20 |
| Joel F. Sussman | 16 |
| J. Sorensen | 16 |
| Susan Knudson | 13 |
| Jennifer Giottonini Cayer | 12 |
| Linda West | 12 |
- Beurs
- Insiders
- Jon T. Holmlund
- Bedrijfsconnecties
